Serum Soluble Interleukin-2 Receptor as a Potential Biomarker for Immune-related Adverse Events.
Takai R, Funakoshi Y, Suto H, Nagatani Y, Imamura Y, Toyoda M, Yakushijin K, Kiyota N, Harada KI, Yamashita K, Kakeji Y, Minami H.
Takai R, et al. Among authors: funakoshi y.
Anticancer Res. 2021 Feb;41(2):1021-1026. doi: 10.21873/anticanres.14857.
Anticancer Res. 2021.
PMID: 33517310